Pulmonx Corporation (LUNG)
LUNG trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.76
-2.22% on the day
Market cap
$75.6M
Micro cap
Revenue · 2025
$90.5M
+8.0% on 2024
Net income · 2025
-$54.0M
-59.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | LUNG on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001127537 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $90.5M |
| Net income | -$54.0M |
| Operating income | -$53.7M |
| Net margin | -59.7% |
| Operating margin | -59.3% |
| Revenue growth | +8.0% |
| Cash | $69.8M |
| Total assets | $129.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-09-26 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-08-04 |
| Latest current report | 8-K | 2026-07-29 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 448 recent filings. All filings on EDGAR.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LNSR | LENSAR Inc. | $6.27 | +0.80% | $77.0M |
| SKIN | SkinHealth Systems Inc. | $0.5406 | +2.97% | $70.4M |
| MBOT | Microbot Medical Inc. | $1.02 | -1.92% | $68.5M |
| QTEX | QTREX Quantum Ltd. | $1.58 | 0.00% | $88.4M |
| DXR | Daxor Corporation | $10.35 | +0.45% | $60.4M |
| PYPD | PolyPid Ltd. | $4.88 | -2.79% | $99.1M |
| DRIO | DarioHealth Corp. | $5.54 | +2.21% | $54.3M |
| GUTS | Fractyl Health Inc. | $4.03 | -8.73% | $53.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier